Ye J, Wu S, Quan Q, Ye F, Zhang J, Song C, Fan Y, Cao H, Tang H, Zhao J. Fibroblast growth factor receptor 4 promotes Triple-Negative breast cancer progression via regulating fatty acid metabolism through the AKT/RYR2 signaling. Cancer Med. 2024;13(23):e70439.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peng WT, Jin X, Xu XE, Yang YS, Ma D, Shao ZM, Jiang YZ. Inhibition of ACAA1 restrains proliferation and potentiates the response to CDK4/6 inhibitors in triple-negative breast cancer. Cancer Res. 2023;83(10):1711–24.

Article  CAS  PubMed  Google Scholar 

Ruiz-Manriquez LM, Estrada‐Meza C, Benavides‐Aguilar JA, Ledesma‐Pacheco SJ, Torres‐Copado A, Serrano‐Cano FI, Bandyopadhyay A, Pathak S, Chakraborty S, Srivastava A, Sharma A. Phytochemicals mediated modulation of MicroRNAs and long non‐coding RNAs in cancer prevention and therapy. Phytother Res. 2022;36(2):705–29.

Article  CAS  PubMed  Google Scholar 

Liao J, Chen B, Zhu Z, Du C, Gao S, Zhao G, Zhao P, Wang Y, Wang A, Schwartz Z, Song L. Long noncoding RNA (lncRNA) H19: an essential developmental regulator with expanding roles in cancer, stem cell differentiation, and metabolic diseases. Genes Dis. 2023;10(4):1351–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sellitto A, Pecoraro G, Giurato G, Nassa G, Rizzo F, Saggese P, Martinez CA, Scafoglio C, Tarallo R. Regulation of metabolic reprogramming by long non-coding RNAs in cancer. Cancers. 2021;13(14):3485.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A CeRNA hypothesis: the Rosetta stone of a hidden RNA language? Cell. 2011;146(3):353–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li D, Zhang J, Li J. Role of MiRNA sponges in hepatocellular carcinoma. Clin Chim Acta. 2020;500:10–9.

Article  CAS  PubMed  Google Scholar 

Zhou B, Guo H, Tang J, Long Non-Coding. RNA TFAP2A-AS1 inhibits cell proliferation and invasion in breast cancer via miR-933/SMAD2. Med Sci Monit. 2019;25:1242–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jie G, Peng S, Cui Z, He C, Feng X, Yang K. Long non-coding RNA TFAP2A-AS1 plays an important role in oral squamous cell carcinoma: research includes bioinformatics analysis and experiments. BMC Oral Health. 2022;22(1):160.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Ma L, Zhang T, Li P, Xu J, Wang Z. Long noncoding RNA TFAP2A-AS1 exerts promotive effects in non-small cell lung cancer progression via controlling the microRNA-548a-3p/CDK4 axis as a competitive endogenous RNA. Oncol Res. 2022;29(2):129–39. https://doi.org/10.32604/or.2022.03563.

Article  PubMed  PubMed Central  Google Scholar 

Niu ZS, Wang WH, Dong XN, Tian LM. Role of long noncoding RNA-mediated competing endogenous RNA regulatory network in hepatocellular carcinoma. World J Gastroenterol. 2020;26(29):4240–60. https://doi.org/10.3748/wjg.v26.i29.4240.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li L, Qin Y, Chen Y. The enzymes of Serine synthesis pathway in cancer metastasis. Biochimica et biophysica acta (BBA)-Mol Cell Res. 2024;19:119697.

Asantewaa G, Harris IS. Glutathione and its precursors in cancer. Curr Opin Biotechnol. 2021;68:292–9.

Article  CAS  PubMed  Google Scholar 

Liu J, Guo S, Li Q, Yang L, Xia Z, Zhang L, Huang Z, Zhang N. Phosphoglycerate dehydrogenase induces glioma cells proliferation and invasion by stabilizing forkhead box M1. J Neurooncol. 2013;111(3):245–55.

Article  CAS  PubMed  Google Scholar 

Rathore R, Schutt CR, Van Tine BA. PHGDH as a mechanism for resistance in metabolically-driven cancers. Cancer Drug Resist. 2020;3(4):762–74. https://doi.org/10.20517/cdr.2020.46. Epub 2020 Sep 17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tajan M, et al. Serine synthesis pathway Inhibition cooperates with dietary Serine and Glycine limitation for cancer therapy. Nat Commun. 2021;12:366.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, et al. Deubiquitinating enzyme Josephin-2 stabilizes PHGDH to promote a cancer stem cell phenotype in hepatocellular carcinoma. Genes Genomics. 2023;45:215–24.

Article  CAS  PubMed  Google Scholar 

Huang G, Li L, Zhou W. USP14 activation promotes tumor progression in hepatocellular carcinoma. Oncol Rep. 2015;34:2917–24.

Article  CAS  PubMed  Google Scholar 

Liao Y, et al. USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells. J Exp Clin Cancer Res. 2021;40:1–16.

Article  Google Scholar 

Itoyama R, et al. Metabolic shift to Serine biosynthesis through 3-PG accumulation and PHGDH induction promotes tumor growth in pancreatic cancer. Cancer Lett. 2021;523:29–42.

Article  CAS  PubMed  Google Scholar 

Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, Sethumadhavan S, Woo HK, Jang HG, Jha AK, et al. Functional genomics reveal that the Serine synthesis pathway is essential in breast cancer. Nature. 2011;476(7360):346–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samanta D, Park Y, Andrabi SA, Shelton LM, Gilkes DM, Semenza GL. PHGDH expression is required for mitochondrial redox homeostasis, breast cancer stem cell maintenance, and lung metastasis. Cancer Res. 2016;76(15):4430–42.

Article  CAS  PubMed  Google Scholar 

Ou Y, Wang S-J, Jiang L, Zheng B, Gu W. p53 Protein-mediated regulation of phosphoglycerate dehydrogenase (PHGDH) is crucial for the apoptotic response upon Serine starvation. J Biol Chem. 2015;290:457–66.

Article  CAS  PubMed  Google Scholar 

Wang C, et al. Acetylation stabilizes phosphoglycerate dehydrogenase by disrupting the interaction of E3 ligase RNF5 to promote breast tumorigenesis. Cell Rep. 2020;32:108021.

Article  CAS  PubMed  Google Scholar 

Li S, Yang H, Li W, Liu JY, Ren LW, Yang YH, Ge BB, Zhang YZ, Fu WQ, Zheng XJ, Du GH. ADH1C inhibits progression of colorectal cancer through the ADH1C/PHGDH/PSAT1/serine metabolic pathway. Acta Pharmacol Sin. 2022;43(10):2709–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Niu C, Wen H, Wang S, Shu G, Wang M, Yi H, Guo K, Pan Q, Yin G. Potential prognosis and immunotherapy predictor TFAP2A in pan-cancer. Aging. 2024;16(2):1021.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang Z, Lou K, Liu H. A novel prognostic signature based on N7-methylguanosine-related long non-coding RNAs in breast cancer. Front Genet. 2022;13:1030275.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang K, Niu Y, Cui Z, Jin L, Peng S, Dong Z. Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR‐1297 and regulating TFAP2A expression. Mol Carcinog. 2022;61(9):865–75.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Ma L, Zhang T, Li P, Xu J, Wang Z. Long noncoding RNA TFAP2A-AS1 exerts promotive effects in non-small cell lung cancer progression via controlling the microRNA-548a-3p/CDK4 axis as a competitive endogenous RNA. Oncol Res. 2021;29(2):129.

Article  PubMed  Google Scholar